Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 55 | 2024 | 3079 | 7.240 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 17 | 2022 | 518 | 3.330 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 6 | 2021 | 236 | 2.780 |
Why?
|
Magnetic Resonance Imaging | 75 | 2024 | 35421 | 2.140 |
Why?
|
Cerebral Cortex | 16 | 2023 | 5708 | 1.900 |
Why?
|
Brain | 36 | 2024 | 26385 | 0.970 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2020 | 3327 | 0.920 |
Why?
|
Spinal Cord | 7 | 2020 | 1809 | 0.920 |
Why?
|
Brain Mapping | 18 | 2019 | 6669 | 0.770 |
Why?
|
Myelin Sheath | 5 | 2024 | 652 | 0.700 |
Why?
|
Trigeminal Nerve | 2 | 2014 | 249 | 0.690 |
Why?
|
Nerve Degeneration | 2 | 2017 | 748 | 0.690 |
Why?
|
Migraine with Aura | 3 | 2020 | 203 | 0.680 |
Why?
|
Hemostatics | 1 | 2021 | 229 | 0.660 |
Why?
|
Interferon-beta | 5 | 2015 | 323 | 0.640 |
Why?
|
Thalamus | 4 | 2020 | 1023 | 0.620 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2015 | 957 | 0.610 |
Why?
|
Receptors, GABA | 3 | 2018 | 288 | 0.570 |
Why?
|
Pyrimidines | 3 | 2019 | 2942 | 0.550 |
Why?
|
Periaqueductal Gray | 2 | 2016 | 107 | 0.520 |
Why?
|
Positron-Emission Tomography | 10 | 2023 | 6234 | 0.520 |
Why?
|
Atrophy | 10 | 2024 | 1583 | 0.520 |
Why?
|
Disease Progression | 17 | 2024 | 13284 | 0.510 |
Why?
|
Microglia | 2 | 2023 | 1266 | 0.500 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2019 | 2737 | 0.490 |
Why?
|
Somatosensory Cortex | 4 | 2013 | 528 | 0.490 |
Why?
|
Meningitis | 1 | 2015 | 216 | 0.460 |
Why?
|
Neural Pathways | 4 | 2016 | 2972 | 0.440 |
Why?
|
Migraine without Aura | 1 | 2013 | 83 | 0.430 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2012 | 32 | 0.420 |
Why?
|
Leukoencephalopathies | 3 | 2022 | 238 | 0.420 |
Why?
|
Cortical Spreading Depression | 2 | 2020 | 276 | 0.410 |
Why?
|
Cerebellum | 1 | 2019 | 1488 | 0.410 |
Why?
|
Inflammation | 4 | 2020 | 10638 | 0.400 |
Why?
|
Gadolinium | 4 | 2015 | 952 | 0.380 |
Why?
|
Migraine Disorders | 2 | 2014 | 1620 | 0.380 |
Why?
|
Adult | 57 | 2020 | 214055 | 0.350 |
Why?
|
Humans | 90 | 2024 | 744343 | 0.330 |
Why?
|
Axons | 7 | 2024 | 1684 | 0.320 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 354 | 0.310 |
Why?
|
Executive Function | 1 | 2016 | 1364 | 0.310 |
Why?
|
Motor Cortex | 5 | 2009 | 986 | 0.310 |
Why?
|
Hyperesthesia | 1 | 2007 | 17 | 0.300 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1179 | 0.300 |
Why?
|
Disability Evaluation | 8 | 2019 | 1827 | 0.290 |
Why?
|
Oxygen | 4 | 2015 | 4189 | 0.270 |
Why?
|
Male | 57 | 2020 | 350118 | 0.270 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2007 | 243 | 0.260 |
Why?
|
Amygdala | 1 | 2013 | 1315 | 0.260 |
Why?
|
Memory | 2 | 2006 | 2174 | 0.260 |
Why?
|
Female | 57 | 2020 | 380194 | 0.250 |
Why?
|
Attention | 2 | 2006 | 2400 | 0.240 |
Why?
|
Cerebral Veins | 2 | 2016 | 156 | 0.240 |
Why?
|
Energy Metabolism | 2 | 2014 | 2899 | 0.240 |
Why?
|
4-Aminopyridine | 1 | 2004 | 81 | 0.240 |
Why?
|
Potassium Channel Blockers | 1 | 2004 | 171 | 0.230 |
Why?
|
Cognition Disorders | 3 | 2015 | 4043 | 0.230 |
Why?
|
Synaptic Transmission | 2 | 2014 | 1178 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 12 | 2020 | 8949 | 0.230 |
Why?
|
Middle Aged | 35 | 2020 | 213383 | 0.230 |
Why?
|
Brain Stem | 1 | 2007 | 846 | 0.200 |
Why?
|
Neuronal Plasticity | 4 | 2006 | 1422 | 0.200 |
Why?
|
Cerebral Ventricles | 1 | 2024 | 544 | 0.200 |
Why?
|
Prospective Studies | 9 | 2022 | 53288 | 0.190 |
Why?
|
Reproducibility of Results | 8 | 2022 | 19905 | 0.190 |
Why?
|
Neuropsychological Tests | 6 | 2018 | 6993 | 0.180 |
Why?
|
Immunotherapy | 1 | 2015 | 4445 | 0.180 |
Why?
|
Meninges | 1 | 2020 | 190 | 0.160 |
Why?
|
Motor Activity | 4 | 2005 | 2714 | 0.160 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 99 | 0.150 |
Why?
|
Nerve Regeneration | 2 | 2019 | 788 | 0.150 |
Why?
|
Gadolinium DTPA | 2 | 2004 | 836 | 0.150 |
Why?
|
Myotonic Dystrophy | 2 | 2009 | 78 | 0.140 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 835 | 0.140 |
Why?
|
Fatigue | 2 | 2004 | 1531 | 0.140 |
Why?
|
Evoked Potentials, Motor | 3 | 2009 | 454 | 0.130 |
Why?
|
Encephalitis | 1 | 2019 | 423 | 0.130 |
Why?
|
Case-Control Studies | 5 | 2018 | 21746 | 0.120 |
Why?
|
Algorithms | 2 | 2014 | 13881 | 0.120 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14722 | 0.120 |
Why?
|
Anisotropy | 1 | 2017 | 1265 | 0.120 |
Why?
|
Electromagnetic Phenomena | 1 | 2015 | 161 | 0.120 |
Why?
|
Afferent Pathways | 1 | 2014 | 302 | 0.110 |
Why?
|
Functional Laterality | 4 | 2015 | 2290 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 1999 | 1017 | 0.110 |
Why?
|
Neuroglia | 1 | 2017 | 927 | 0.100 |
Why?
|
Adjuvants, Immunologic | 3 | 2002 | 1000 | 0.100 |
Why?
|
Fibromyalgia | 1 | 2016 | 388 | 0.100 |
Why?
|
Corpus Callosum | 3 | 2022 | 737 | 0.100 |
Why?
|
Movement Disorders | 1 | 2015 | 445 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4042 | 0.100 |
Why?
|
Nociceptors | 1 | 2014 | 432 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2017 | 944 | 0.080 |
Why?
|
Physical Stimulation | 2 | 2007 | 525 | 0.080 |
Why?
|
Touch | 2 | 2007 | 306 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1414 | 0.080 |
Why?
|
Consensus | 1 | 2016 | 2959 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2015 | 854 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15540 | 0.070 |
Why?
|
Trigeminal Nuclei | 1 | 2006 | 41 | 0.070 |
Why?
|
Cohort Studies | 4 | 2018 | 40561 | 0.070 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2009 | 356 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13989 | 0.070 |
Why?
|
Nerve Net | 1 | 2018 | 2174 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 25043 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39050 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.060 |
Why?
|
Neurons, Afferent | 1 | 2007 | 506 | 0.060 |
Why?
|
Psychomotor Performance | 3 | 2007 | 1901 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2902 | 0.060 |
Why?
|
Pain Threshold | 1 | 2007 | 584 | 0.060 |
Why?
|
Risk | 1 | 2015 | 9687 | 0.050 |
Why?
|
Cognition | 2 | 2014 | 6770 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 56430 | 0.050 |
Why?
|
Movement | 1 | 2009 | 1471 | 0.050 |
Why?
|
Diffusion | 1 | 2024 | 833 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
Reaction Time | 2 | 2007 | 2097 | 0.050 |
Why?
|
Models, Neurological | 3 | 2009 | 1774 | 0.050 |
Why?
|
Magnetics | 1 | 2004 | 606 | 0.050 |
Why?
|
Pyramidal Tracts | 1 | 2002 | 256 | 0.050 |
Why?
|
Aged | 8 | 2020 | 163280 | 0.050 |
Why?
|
Brain Chemistry | 2 | 2013 | 981 | 0.050 |
Why?
|
Disabled Persons | 3 | 2005 | 1212 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15076 | 0.040 |
Why?
|
Fibrin | 1 | 2022 | 506 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.040 |
Why?
|
Creatine | 1 | 2001 | 421 | 0.040 |
Why?
|
Hemostasis | 1 | 2022 | 458 | 0.040 |
Why?
|
Electromyography | 1 | 2004 | 1379 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2000 | 326 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2001 | 576 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2029 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 379 | 0.040 |
Why?
|
Home Care Services | 1 | 2004 | 606 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 2 | 2019 | 2305 | 0.040 |
Why?
|
Mental Recall | 1 | 2004 | 1205 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2004 | 975 | 0.040 |
Why?
|
Estradiol | 1 | 2005 | 2020 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 577 | 0.030 |
Why?
|
Observer Variation | 2 | 2018 | 2593 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2015 | 63114 | 0.030 |
Why?
|
Spinal Cord Diseases | 1 | 2019 | 298 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1999 | 551 | 0.030 |
Why?
|
Apomorphine | 1 | 1995 | 150 | 0.030 |
Why?
|
Skull | 1 | 2020 | 813 | 0.030 |
Why?
|
Contrast Media | 4 | 2004 | 5300 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 9981 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
Down-Regulation | 1 | 2002 | 3002 | 0.030 |
Why?
|
Testosterone | 1 | 2005 | 2420 | 0.030 |
Why?
|
Antibodies | 1 | 2002 | 2460 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6442 | 0.030 |
Why?
|
Narcotics | 1 | 1995 | 343 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 1995 | 355 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2252 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1855 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2002 | 1580 | 0.030 |
Why?
|
Heart | 1 | 2006 | 4467 | 0.030 |
Why?
|
Caregivers | 1 | 2004 | 2094 | 0.030 |
Why?
|
Estrogens | 1 | 1999 | 1566 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 1005 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 1790 | 0.030 |
Why?
|
Adolescent | 8 | 2020 | 85781 | 0.030 |
Why?
|
Paresis | 2 | 2002 | 179 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4034 | 0.020 |
Why?
|
Polysomnography | 1 | 2017 | 1776 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2004 | 12026 | 0.020 |
Why?
|
Cocaine | 1 | 1995 | 1007 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
Rats | 2 | 2024 | 24260 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2018 | 6365 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3760 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2009 | 1432 | 0.020 |
Why?
|
Neurophysiology | 1 | 2009 | 142 | 0.020 |
Why?
|
Paresthesia | 1 | 2009 | 161 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2015 | 77449 | 0.020 |
Why?
|
Recurrence | 1 | 1999 | 8340 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Regression Analysis | 2 | 2007 | 6459 | 0.020 |
Why?
|
Reference Values | 2 | 2004 | 4982 | 0.020 |
Why?
|
Pons | 1 | 2006 | 245 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12959 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2004 | 147 | 0.020 |
Why?
|
Depression | 1 | 2004 | 7766 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 21827 | 0.010 |
Why?
|
Trinucleotide Repeats | 1 | 2004 | 261 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1285 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2004 | 367 | 0.010 |
Why?
|
Motor Skills | 1 | 2006 | 522 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2007 | 1767 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2004 | 880 | 0.010 |
Why?
|
Animals | 3 | 2024 | 168757 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12245 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 635 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2004 | 930 | 0.010 |
Why?
|
Optic Neuritis | 1 | 2002 | 166 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2002 | 421 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2002 | 376 | 0.010 |
Why?
|
Hemodynamics | 1 | 2009 | 4199 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1813 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2002 | 838 | 0.010 |
Why?
|
Drug Interactions | 1 | 2002 | 1460 | 0.010 |
Why?
|
Hand | 1 | 2002 | 884 | 0.010 |
Why?
|
Steroids | 1 | 2002 | 930 | 0.010 |
Why?
|
Affect | 1 | 2004 | 1476 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2002 | 1312 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1530 | 0.010 |
Why?
|
Time Factors | 3 | 2002 | 40075 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1995 | 337 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4933 | 0.010 |
Why?
|
Patient Care Team | 1 | 2004 | 2531 | 0.010 |
Why?
|
Acute Disease | 1 | 2002 | 7149 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 6489 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10397 | 0.010 |
Why?
|
Software | 1 | 2004 | 4443 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9338 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57776 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8301 | 0.000 |
Why?
|
Blood Glucose | 1 | 1995 | 6256 | 0.000 |
Why?
|
Concepts
(224)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_